Concepedia

Xiangzhi Meng

XM

51

Publications

3.2K

Citations

31

H-Index

2006

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

Oklahoma State University

La Jolla Institute for Immunology

Bipar

University of Arizona

Xiangzhi Meng is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, virology, and immunology.

ORCID

Top concepts

Publications per year

2006–2023

51

Publications

51

Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L

M. Sacco, Chunlong Ma, Panagiotis Lagarias et al. · Science Advances · 2020 · 390 citations · Full text

Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

Shuofeng Yuan, Xin Yin, Xiangzhi Meng et al. · Nature · 2021 · 200 citations · Full text

Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay

Chunlong Ma, M. Sacco, Zilei Xia et al. · ACS Central Science · 2021 · 191 citations · Full text

The <i>in vitro</i> antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor

Yanmei Hu, Xiangzhi Meng, Fushun Zhang et al. · Emerging Microbes & Infections · 2021 · 185 citations · Full text

Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors

Naoya Kitamura, M. Sacco, Chunlong Ma et al. · Journal of Medicinal Chemistry · 2021 · 156 citations · Full text

Rows per page

1–5 of 51